# Boom-IBD Clinical Trial

> **NCT05414955** · NA · COMPLETED · sponsor: **Boomerang Medical** · enrollment: 40 (actual)

## Conditions studied

- IBD

## Interventions

- **DEVICE:** Neuromodulation

## Key facts

- **NCT ID:** NCT05414955
- **Lead sponsor:** Boomerang Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-01
- **Primary completion:** 2024-12-06
- **Final completion:** 2024-12-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05414955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05414955, "Boom-IBD Clinical Trial". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05414955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*